Comment
doi: 10.1111/bjh.14905.
Epub 2017 Aug 18.
Interim FDG-PET has no value in selecting patients who require treatment modification in both early- and advanced-stage Hodgkin lymphoma: response to Adams and Kwee
Affiliations
- PMID: 28832981
- DOI: 10.1111/bjh.14905
Item in Clipboard
Comment
Interim FDG-PET has no value in selecting patients who require treatment modification in both early- and advanced-stage Hodgkin lymphoma: response to Adams and Kwee
Br J Haematol.
2018 Oct.
No abstract available
Keywords: Hodgkin lymphoma (HL); advanced-stage Hodgkin lymphoma (advanced-HL); early-stage Hodgkin lymphoma (early-HL); interim PET/CT (PET-2); radiation therapy (RT).
Comment on
-
Modification of initial therapy in early and advanced Hodgkin lymphoma, based on interim PET/CT is beneficial: a prospective multicentre trial of 355 patients.Br J Haematol. 2017 Sep;178(5):709-718. doi: 10.1111/bjh.14734. Epub 2017 Jun 7. Br J Haematol. 2017. PMID: 28589704 Clinical Trial.
-
Interim FDG-PET has no value in selecting patients who require treatment modification in both early- and advanced-stage Hodgkin lymphoma.Br J Haematol. 2018 Oct;183(1):129-131. doi: 10.1111/bjh.14906. Epub 2017 Sep 14. Br J Haematol. 2018. PMID: 28905368 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
